Medicine and Dentistry
Human Immunodeficiency Virus
100%
Patient
76%
Infection
60%
Outpatient
46%
Therapeutic Procedure
37%
Person
35%
Injection
31%
Opioid Abuse
29%
Drug
29%
Antimicrobial Therapy
28%
Antibiotic Therapy
25%
Buprenorphine
23%
Medical Care
23%
Older Adult
18%
Primary Health Care
18%
Follow up
16%
Drug Use
15%
Physician
14%
Clinician
12%
Alcohol Consumption
10%
Perception
10%
HIV/AIDS
10%
Hospital
9%
Cohort Effect
9%
Rhodococcus equi
9%
Nitrite
9%
Bone Pain
9%
Pericarditis
9%
Vaginal Trichomoniasis
9%
Pancreatitis
9%
Multiple Chronic Conditions
9%
Prenatal Care
9%
Infectious Disease Clinics
9%
Decision Making
9%
Retainer
9%
Illicit Drug
9%
Clinical Management
9%
Association
9%
Randomized Clinical Trial
9%
Infectious Complication
9%
Reproductive Medicine
9%
Zidovudine
9%
Seroprevalence
9%
Macrocytosis
9%
Metronidazole
9%
Omeprazole
9%
near Drowning
9%
Invasive Aspergillosis
9%
Fulminant
9%
Immunity
9%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
53%
HIV
45%
Zidovudine
29%
Cotrimoxazole
29%
Disease
22%
Drug
20%
Ulcus molle
18%
Antimicrobial Therapy
17%
Antibiotic Therapy
15%
Opiate
12%
Azithromycin
12%
Pneumonia
11%
Controlled Clinical Trial
11%
Streptococcus Pneumonia
11%
Ciprofloxacin
10%
Omeprazole
9%
Acute Gastroenteritis
9%
Buprenorphine
9%
Equus
9%
Illicit Drug
9%
Norovirus
9%
Influenza
9%
Megalocytosis
9%
Infectious Complication
9%
Nitrite
9%
Rhodococcosis
9%
Proteinase Inhibitor
9%
Epidemiology
9%
Randomized Clinical Trial
9%
Incidence
9%
Immunoglobulin
9%
Acute Kidney Failure
9%
Bacterial Endocarditis
9%
Oxidized Low Density Lipoprotein
9%
Papule
9%
Levofloxacin
9%
Pancreatitis
9%
Immunotherapy
9%
Hemolysin
9%
Metronidazole
9%
Symptom
9%
Vaginal Trichomoniasis
9%
Quinolone Derivative
9%
Cardiovascular Disease
9%
Vaccination
9%
Antimicrobial Agent
9%
near Drowning
9%
Invasive Aspergillosis
9%
Mitogenic Agent
7%
Penicillin Derivative
7%
Nursing and Health Professions
Human Immunodeficiency Virus
95%
Patient
63%
Time
41%
Older Adult
28%
Outpatient
23%
Drug
21%
Primary Medical Care
18%
Antimicrobial Therapy
18%
Prevention
18%
Zidovudine
18%
Procedures
15%
Person
14%
Infection
13%
Disease
12%
Injection
12%
Hospital
12%
Virus Load
11%
Highly Active Antiretroviral Therapy
11%
Inpatient
9%
Opiate
9%
Megalocytosis
9%
Foreign Born
9%
Drug Therapy
9%
Proteinase Inhibitor
9%
Analysis
9%
Buprenorphine
9%
Influenza Vaccination
9%
Cotrimoxazole
9%
Prenatal Care
9%
Seroprevalence
9%
Endocarditis
9%
Comorbidity
9%
Follow up
8%
Drug Use
7%
Area under the Curve
6%
Confidence Interval
5%
